These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5960703)

  • 1. Changes in total and ultrafilterable plasma calcium and magnesium during hemodialysis.
    Ogden DA; Holmes JH
    Trans Am Soc Artif Intern Organs; 1966; 12():200-4. PubMed ID: 5960703
    [No Abstract]   [Full Text] [Related]  

  • 2. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: calcium.
    Gotch F
    Semin Dial; 2008; 21(5):411-4. PubMed ID: 18945329
    [No Abstract]   [Full Text] [Related]  

  • 3. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of changes in levels of calcium, phosphate and magnesium during hemodialysis on autonomic system reactivity as measured by heart rate variability analysis].
    Buda S; Stompór T; Sułowicz W; Kopeć J; Szymczakiewicz-Multanowska A; Janion M
    Przegl Lek; 2000; 57(6):340-5. PubMed ID: 11107869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients.
    Saha H; Harmoinen A; Pietilä K; Mörsky P; Pasternack A
    Clin Nephrol; 1996 Nov; 46(5):326-31. PubMed ID: 8953122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the electrocardiogram and electrolyte changes in programmed hemodialysis].
    Verkhovskiĭ BD; Shcherbakova EO; Soldatkina LV; Ivanova ZIa
    Sov Med; 1973 Oct; 36(10):116-21. PubMed ID: 4789194
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis.
    Varghese Z; Moorhead JF; Wills MR
    Lancet; 1973 Nov; 302(7836):985-8. PubMed ID: 4127276
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

  • 9. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
    Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
    ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monostatic localization of bone dystrophy in patients under hemodialysis for chronic renal insufficiency].
    Noè C
    Arch Ital Urol Nefrol; 1971; 43(4):251-7. PubMed ID: 5130445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apropos of the optimal calcium level in the dialysis bath].
    Verberckmoes R; Bouillion R
    Minerva Nefrol; 1973; 20(6):368-73. PubMed ID: 4792773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of tap water on the level of plasma magnesium in patients with terminal stage of chronic renal insufficiency treated by hemodialysis].
    Bazhanova IM; Levitskiĭ ER
    Urol Nefrol (Mosk); 1975; (1):35-8. PubMed ID: 1118971
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
    McGonigle RJ; Weston MJ; Keenan J; Jackson DB; Parsons V
    Magnesium; 1984; 3(1):1-7. PubMed ID: 6482508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation of post-dialysis plasma calcium and magnesium to the dialysate levels and to changes in blood pH.
    Danesh JN; Walker CH; Mathers NP
    N Engl J Med; 1970 Apr; 282(14):771-5. PubMed ID: 5416970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Magnesium and the treatment by repeated hemodialysis].
    Aebischer N; Fellay G
    Rev Med Suisse Romande; 1982 Sep; 102(9):853-5. PubMed ID: 7146712
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of Ca and Mg concentrations in plasma and erythrocytes during hemodialysis].
    Paschen K; Henning HV; Quellhorst E; Scheler F
    Klin Wochenschr; 1971 Dec; 49(24):1314-8. PubMed ID: 5138341
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
    Spiegel DM; Farmer B; Smits G; Chonchol M
    J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of the composition of the dialyzing solution during its electrochemical regeneration].
    Maksimov EP; Leshchinskiĭ GM; Grinval'd VM; Fomicheva NN; Shadiev BSh
    Med Tekh; 2003; (2):8-10. PubMed ID: 12924213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
    Konstantinova OV; Ianenko EK; Danilkov AP; Pashkin IN
    Urol Nefrol (Mosk); 1997; (3):23-5. PubMed ID: 9245050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.